Loading
GP
Genix Pharmaceucticals Corporation Stock: price and insider trades · Canada
Genix Pharmaceucticals Corporation: what insiders have been doing
We have very little insider data for Genix Pharmaceucticals Corporation so far: the most recent filing dates from 22 January 2020. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€276
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 22 January 2020
Declarations2 total
Common SharesTSXSEDI:3487299
5,000 shares@ CA$0.08100.0% of flowCommon SharesTSXSEDI:3487302
Canonical exit: 21 Apr 2020 (T+90)
2 of 2 declarations
About Genix Pharmaceucticals Corporation
Genix Pharmaceuticals Corporation is a company listed on the Toronto Stock Exchange, specializing in the development and marketing of pharmaceutical products. It focuses on innovative solutions to enhance patient health.
